The present review summarizes the findings on circulating S100B levels (serum or plasma) in five major psychiatric disorders: schizophrenia, major depressive disorder, bipolar disorder, autistic spectrum disorder, and attention-deficit/hyperactivity disorder. This evidence concerns the gene S100B and major depressive disorder.